Pharmacokinetics of Nitrosoureas: Levels of 1,3-Bis-(2-Chloroethyl)-1-Nitrosourea (Bcnu) in Organs of Normal and Walker 256/B Carcinoma Bearing Rats after I.V. Bolus
Restricted accessResearch articleFirst published online December, 1984
Pharmacokinetics of Nitrosoureas: Levels of 1,3-Bis-(2-Chloroethyl)-1-Nitrosourea (Bcnu) in Organs of Normal and Walker 256/B Carcinoma Bearing Rats after I.V. Bolus
The disappearance of 1,3-bis-(2-chlorethyl)-1-nitrosourea (BCNU) from plasma, liver, kidney, lung, brain, spleen, tumor tissue and epididymal adipose tissue of Walker 256/B carcinoma-bearing rats and healthy animals was measured by differential pulse polarography after i.v. bolus of the drug. Only BCNU, not its decomposition products, was detected by the Polarographic assay. Levels of BCNU in liver of tumor-bearing animals were significantly lower (about 10 times) than those on healthy rats. A bi-exponential fit was used to calculate the kinetics of BCNU in plasma, kidney, lung and brain, but no difference could be found between healthy and Walker tumor-bearing rats. BCNU disappeared faster from adipose tissue of tumor-bearing animals than from normals.
Get full access to this article
View all access options for this article.
References
1.
BartošekI., DonelliM.G., GuaitaniA.: Modification of drug metabolism induced in the host by the presence of a tumor. Recent Results Cancer Res., 49: 95–100, 1975.
2.
BartošekI., DonelliM.G., GuaitaniA., ColomboT., RussoR., GarattiniS.: Differences of cyclophosphamide and 6-mercaptopurine metabolic rates in perfused liver of normal and tumor-bearing animals. Biochem. Pharmacol., 24: 289–291, 1975.
3.
BartošekI., DanielS., SykoraS.: Differential pulse Polarographic determination of submicrogram quantities of carmustine and related compounds in biological samples. J. Pharm. Sci., 67: 1160–1163, 1978.
4.
ColvinM., BrundrettR.B., CowensW., JardineJ., LudlumD.B.: A chemical basis for the antitumoral activity of chloroethylnitrosoureas. Biochem. Pharmacol., 25: 695–699, 1976.
5.
De VitaV.I., DenhamC., DavidsonJ.D., OliverioV.I.: The physiological disposition of the carcinostatic 1,3-bis(3-chloroethyl)-1-nitrosourea (BCNU) in man and animals. Clin. Pharm. Ther., 8: 566–577, 1967.
6.
FiebigH.H., EisenbrandG., ZellerW.J., Deutsch-WenzelT.: Water soluble derivatives and bifunctional analogs of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Eur. J. Cancer, 13: 937–945, 1977.
7.
GeranR.J., GreenbergN.H., MacdonaldM.M., SchumacherA.M., AbbottD.J.: Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep., 3: part, 3, 15, 1972.
8.
GibaldiN., PerrierD.: Pharmacokinetics.Marcel Dekker, New York, 1975.
9.
GuaitaniA., Della TorreP., MorascaL., PintusC., BartošekI.: Two lines of Walker carcinoma 256: Their peculiarities and different interactions with the host. Tumori, 69: 1–9, 1983.
10.
HillD.L., KirkM.C., StruckR.F.: Microsomal metabolism of nitrosoureas. Cancer Res., 35: 296–301, 1975.
11.
LevinV.A., KabraP.A., Freeman DoveM.A.: Relationship of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors. Cancer Chemother. Pharmacol., 1: 233–242, 1978.
12.
LevinV.A., HoffmanW., WeinkamR.J.: Pharmacokinetics of BCNU in man: A preliminary study of 20 patients. Cancer Treat. Rep., 62: 1305–1312, 1978.
13.
LevinV.A., StearnsJ., ByrdA., FinnA., WeinkamR.J.: The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU. J. Pharmacol. Exp. Ther., 208: 1–6, 1979.
14.
MontgomeryJ.A., JamesR., McCalebG.S., JohnstonT.P.: The modes of decomposition of 1,3-bis (2-chloroethyl)-1-nitrosourea and related compounds. J. Med. Chem., 10: 668–699, 1967.
15.
OliverioV.T., VietzkeW.M., WilliamsM.K., AdamsonR.H.: The adsorption, distribution, excretion and biotransformation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in animals. Cancer Res., 30: 1330–1337, 1970.
16.
RussoR., BartošekI., PiazzaE., SantiA.M., LibrettiA., GarattiniS.: Differential pulse Polarographic determination of pharmacokinetics of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in patients with lung cancer. Cancer Treat. Rep., 65: 555–562, 1981.
17.
VillaP., GuaitaniA., BartošekI.: Differences in pentobarbital disappearance rate in rats bearing two lines of Walker carcinosarcoma 256. Biochem. Pharmacol., 27: 811–812, 1978.
18.
WeinkamR.J., LiuT.-Y.J., LinH.-S.: Protein mediated chemical reactions of chloroethylnitrosourea. Chem. Biol. Interact., 31: 167–177, 1980.
